(six from the second outbreak). Type C included 12 isolates (one from
September 2010). Clusters identified by the DiversiLab method
were compared with our in-house library of worldwide
carbapenem-resistant isolates to determine their epidemiological
background.13 The predominant clone (PFGE pulsotype
1, rep-PCR types B and C) corresponded to the international
clone (IC) 2. Isolates representing pulsotypes 2 and 3 (rep-PCR
type A) were assigned to IC 1 (Figure 2).